+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United Kingdom Transcatheter Heart Valves Market Outlook to 2036 - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR) and Others

  • PDF Icon

    Report

  • 55 Pages
  • April 2026
  • Region: United Kingdom
  • GlobalData
  • ID: 5987339
The “United Kingdom Transcatheter Heart Valves Outlook to 2036” is a comprehensive databook report, covering key market data on the United Kingdom Transcatheter Heart Valves market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Implantation (TMVI), Transcatheter Mitral Valve Repair (TMVR), Transcatheter Pulmonary Valve Replacement (TPVR) and Transcatheter Tricuspid Valve Repair and Replacement

The United Kingdom Transcatheter Heart Valves Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Transcatheter Heart Valves Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Transcatheter Heart Valves Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Transcatheter Heart Valves is segmented as follows:

  • Transcatheter Aortic Valve Replacement (TAVR)
  • Transcatheter Mitral Valve Implantation (TMVI)
  • Transcatheter Mitral Valve Repair (TMVR)
  • Transcatheter Pulmonary Valve Replacement (TPVR)
  • Transcatheter Tricuspid Valve Repair and Replacement

Reasons to Buy

The United Kingdom Transcatheter Heart Valves Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Transcatheter Heart Valves Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Transcatheter Heart Valves Market, North America
2.1 Transcatheter Heart Valves Market, North America, Revenue ($m), 2024-2036
2.2 Transcatheter Heart Valves Market, North America, Revenue ($m), 2024-2036
2.3 Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
2.4 Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
2.5 Transcatheter Heart Valves Market, North America, Company Share by Revenue ($m), 2025
3 Transcatheter Heart Valves Market, Canada
3.1 Transcatheter Heart Valves Market, Canada, Revenue ($m), 2024-2036
3.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Transcatheter Heart Valves Market, Canada, Volume (Units), 2024-2036
3.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Transcatheter Heart Valves Market, Canada, Average Price ($), 2024-2036
3.4 Transcatheter Heart Valves Market, Canada, Company Share by Revenue ($m), 2025
4 Transcatheter Heart Valves Market, Mexico
4.1 Transcatheter Heart Valves Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Transcatheter Heart Valves Market, Mexico, Volume (Units), 2024-2036
4.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Transcatheter Heart Valves Market, Mexico, Average Price ($), 2024-2036
4.4 Transcatheter Heart Valves Market, Mexico, Company Share by Revenue ($m), 2025
5 Transcatheter Heart Valves Market, United States
5.1 Transcatheter Heart Valves Market, United States, Revenue ($m), 2024-2036
5.1.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
5.2.1 Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Transcatheter Heart Valves Market, United States, Average Price ($), 2024-2036
5.4 Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), 2025
6 Transcatheter Heart Valves Market Pipeline Products
6.1 Transcatheter Heart Valves Market Pipeline Products
6.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development
6.3 Transcatheter Heart Valves - Pipeline Products by Segment
6.4 Transcatheter Heart Valves - Pipeline Products by Territory
6.5 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
6.6 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Transcatheter Heart Valves Market
7.1 Edwards Lifesciences Corp
7.1.1 Company Overview
7.2 Medtronic Plc
7.2.1 Company Overview
7.3 Abbott Laboratories
7.3.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Jan 29, 2026: JenaValve Appoints John Molyneux to Vice President of Operations
8.1.2 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.1.3 Oct 30, 2025: 100 Million Gift Advances UCSF’s Dementia Research and Care
8.1.4 Oct 30, 2025: Edwards Lifesciences CFO Transition Plan Announced
8.1.5 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.1.6 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
8.1.7 Oct 08, 2025: Job Opportunity at the Adaptive Brain Lab: Research Programme Manager Position
8.1.8 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.9 Oct 01, 2025: MRC Centre Of Research Excellence Round Four Now Open Internal Deadline 21st Oct 2025
8.1.10 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
8.1.11 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
8.2 Financial Announcements
8.2.1 Feb 03, 2026: Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
8.2.2 Oct 23, 2025: Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
8.2.3 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
8.2.4 Jul 18, 2025: Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
8.3 Government and Public Interest
8.3.1 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
8.3.2 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.3.3 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
8.4 Other Significant Developments
8.4.1 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
8.4.2 Oct 16, 2025: Excision Of A Six-Year-Old Evolut CoreValve TAVR
8.4.3 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
8.5 Product News
8.5.1 Nov 24, 2025: JenaValve Publishes ALIGN-AR Trial Results in The Lancet and at PCR London Valves
8.5.2 Nov 17, 2025: Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves
8.5.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.5.4 Nov 10, 2025: JenaValve's Trilogy System Featured in Live Procedure at TCT 2025
8.5.5 Oct 27, 2025: Successful Patient Outcomes With Edwards’ SAPIEN M3 and EVOQUE Systems
8.5.6 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets
8.5.7 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial
8.5.8 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.5.9 Sep 10, 2025: JenaValve Announces ESC Guidelines Recognize TAVI for Aortic Regurgitation
8.6 Strategy And Business Planning
8.6.1 Oct 19, 2025: MicroPort® HeartLink Catheter Aortic Valve System Launches In Mexico, Achieving Full Coverage In Five Major Latin American Markets
8.6.2 Sep 11, 2025: Penumbra, Inc. Establishes Manufacturing Plant in Costa Rica
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer
List of Tables
Table 1: Transcatheter Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Transcatheter Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
Table 4: Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
Table 5: Transcatheter Heart Valves Market, North America, Company Share by Revenue ($m), 2025
Table 6: Transcatheter Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Transcatheter Heart Valves Market, Canada, Volume (Units), 2024-2036
Table 9: Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Volume (Units), 2024-2036
Table 10: Transcatheter Heart Valves Market, Canada, Average Price ($), 2024-2036
Table 11: Transcatheter Heart Valves Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 12: Transcatheter Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 13: Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 14: Transcatheter Heart Valves Market, Mexico, Volume (Units), 2024-2036
Table 15: Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Volume (Units), 2024-2036
Table 16: Transcatheter Heart Valves Market, Mexico, Average Price ($), 2024-2036
Table 17: Transcatheter Heart Valves Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 18: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 19: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 20: Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
Table 21: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2024-2036
Table 22: Transcatheter Heart Valves Market, United States, Average Price ($), 2024-2036
Table 23: Transcatheter Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 24: Transcatheter Heart Valves Market Pipeline Products
Table 25: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Table 26: Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
Table 27: Transcatheter Heart Valves - Pipeline Products by Segment
Table 28: Transcatheter Heart Valves - Pipeline Products by Territory
Table 29: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Table 30: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
Table 31: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Transcatheter Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Transcatheter Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
Figure 4: Transcatheter Heart Valves Market, North America, Volume (Units), 2024-2036
Figure 5: Transcatheter Heart Valves Market, North America, Company Share (%), 2025
Figure 6: Transcatheter Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Transcatheter Heart Valves Market, Canada, Volume (Units), 2024-2036
Figure 9: Transcatheter Tricuspid Valve Repair and Replacement Market, Canada, Volume (Units), 2024-2036
Figure 10: Transcatheter Heart Valves Market, Canada, Company Share (%), 2025
Figure 11: Transcatheter Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 12: Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 13: Transcatheter Heart Valves Market, Mexico, Volume (Units), 2024-2036
Figure 14: Transcatheter Tricuspid Valve Repair and Replacement Market, Mexico, Volume (Units), 2024-2036
Figure 15: Transcatheter Heart Valves Market, Mexico, Company Share (%), 2025
Figure 16: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 17: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 18: Transcatheter Heart Valves Market, United States, Volume (Units), 2024-2036
Figure 19: Transcatheter Tricuspid Valve Repair and Replacement Market, United States, Volume (Units), 2024-2036
Figure 20: Transcatheter Heart Valves Market, United States, Company Share (%), 2025
Figure 21: Transcatheter Heart Valves - Pipeline Products by Stage of Development
Figure 22: Transcatheter Heart Valves - Pipeline Products by Segment
Figure 23: Transcatheter Heart Valves - Pipeline Products by Territory
Figure 24: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
Figure 25: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Edwards Lifesciences Corp
  • Medtronic Plc
  • Abbott Laboratories